{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:36:54Z","timestamp":1784054214253,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.rdc.2021.07.010","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:15:03Z","timestamp":1630534503000},"page":"531-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["CARRA"],"prefix":"10.1016","volume":"47","author":[{"given":"Robert C.","family":"Fuhlbrigge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Schanberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.rdc.2021.07.010_bib1","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.1780400627","article-title":"Pediatric rheumatology: status of the subspecialty in United States medical schools","volume":"40","author":"Cassidy","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.010_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1203\/01.PDR.0000182823.85717.48","article-title":"The history of pediatric rheumatology","volume":"58","author":"Schaller","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.rdc.2021.07.010_bib3","series-title":"History of Pediatric Rheumatology. In: Sawhney S., Aggarwal A. (eds) Pediatric Rheumatology. Springer, Singapore.","first-page":"3","author":"Athreya","year":"2017"},{"key":"10.1016\/j.rdc.2021.07.010_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1546-0096-6-5","article-title":"Research priorities in pediatric rheumatology: the Childhood Arthritis and Rheumatology Research Alliance (CARRA) consensus","volume":"6","author":"Ota","year":"2008","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.010_bib5","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/art.24469","article-title":"Premature atherosclerosis in pediatric systemic lupus erythematosus: risk factors for increased carotid intima-media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohort","volume":"60","author":"Schanberg","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.010_bib6","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1002\/art.34343","article-title":"Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis","volume":"64","author":"Wallace","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.rdc.2021.07.010_bib7","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/art.38699","article-title":"Randomized, double-blind, placebo-controlled trial of the efficacy and safety of rilonacept in the treatment of systemic juvenile idiopathic arthritis","volume":"66","author":"Ilowite","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.010_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/art.40395","article-title":"The childhood arthritis and rheumatology research alliance consensus treatment plans: toward comparative effectiveness in the pediatric rheumatic diseases","volume":"70","author":"Ringold","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.010_bib9","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/acr.21687","article-title":"Development of consensus treatment plans for juvenile localized scleroderma: a roadmap toward comparative effectiveness studies in juvenile localized scleroderma","volume":"64","author":"Li","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.rdc.2021.07.010_bib10","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/acr.20071","article-title":"Protocols for the initial treatment of moderately severe juvenile dermatomyositis: results of a Children's Arthritis and Rheumatology Research Alliance Consensus Conference","volume":"62","author":"Huber","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3899\/jrheum.160688","article-title":"Childhood arthritis and rheumatology research alliance consensus clinical treatment plans for juvenile dermatomyositis with persistent skin rash","volume":"44","author":"Huber","year":"2017","journal-title":"J\u00a0Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.010_bib12","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/acr.20695","article-title":"Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference","volume":"64","author":"Huber","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12969-020-00424-x","article-title":"Consensus treatment plans for periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome (PFAPA): a framework to evaluate treatment responses from the childhood arthritis and rheumatology research alliance (CARRA) PFAPA work group","volume":"18","author":"Amarilyo","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"issue":"4","key":"10.1016\/j.rdc.2021.07.010_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/acr.23610","article-title":"Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis","volume":"71","author":"Angeles-Han","year":"2019","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-016-0134-0","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus clinical treatment plans for juvenile dermatomyositis with skin predominant disease","volume":"15","author":"Kim","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"10.1016\/j.rdc.2021.07.010_bib16","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/acr.21558","article-title":"Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus","volume":"64","author":"Mina","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.010_bib17","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1002\/acr.22259","article-title":"Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis","volume":"66","author":"Ringold","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"7","key":"10.1016\/j.rdc.2021.07.010_bib18","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1002\/acr.21625","article-title":"Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis","volume":"64","author":"DeWitt","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12969-017-0157-1","article-title":"Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans","volume":"15","author":"Kimura","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12969-018-0279-0","article-title":"Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis","volume":"16","author":"Cooper","year":"2018","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"10.1016\/j.rdc.2021.07.010_bib21","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3899\/jrheum.190311","article-title":"Initial results from a pilot comparative effectiveness study of 3 methotrexate-based consensus treatment plans for juvenile localized scleroderma","volume":"47","author":"Li","year":"2020","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib22","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3899\/jrheum.190494","article-title":"Pilot study of the juvenile dermatomyositis consensus treatment plans: a CARRA registry study","volume":"48","author":"Liu","year":"2021","journal-title":"J\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2021.07.010_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12969-017-0160-6","article-title":"The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12\u00a0months","volume":"15","author":"Beukelman","year":"2017","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"10.1016\/j.rdc.2021.07.010_bib24","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/acr.20128","article-title":"Monitoring the long-term safety of therapies for children with juvenile idiopathic arthritis: time for a consolidated patient registry","volume":"62","author":"Smith","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"10.1016\/j.rdc.2021.07.010_bib25","doi-asserted-by":"crossref","first-page":"e1384","DOI":"10.1542\/peds.2013-0755","article-title":"Using registries to identify adverse events in rheumatic diseases","volume":"132","author":"Lionetti","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.rdc.2021.07.010_bib26","author":"Kimura","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2021.07.010_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/art.41892","article-title":"Improved disease course associated with early initiation of biologics in untreated polyarticular juvenile idiopathic arthritis: a trajectory analysis of the STOP-JIA study","author":"Ong","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"10.1016\/j.rdc.2021.07.010_bib28","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/art.41043","article-title":"Toward accelerated authorization and access to new medicines for juvenile idiopathic arthritis","volume":"71","author":"Schanberg","year":"2019","journal-title":"Arthritis Rheumatol"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21011042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X21011042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:20:56Z","timestamp":1760181656000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X21011042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0889857X21011042"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.010","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CARRA","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2021.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}